pharmaceutical lawsuit

Tag Archive

Major Win for Dangerous Drug Victims

Major Win for Dangerous Drug Victims

| Pharmaceutical Litigation
A Philadelphia jury ordered Johnson & Johnson subsidiary Janssen Pharmaceuticals to pay $8 billion in a drug-induced gynecomastia matter.  26-year-old Nicholas Murray developed abnormally large breasts in 2003. He had been taking Risperdal, an antipsychotic drug, to control his autism spectrum disorder symptoms. In a statement, J&J said it would appeal the “grossly disproportionate” award.…Read the article
Two More Blood Pressure Drugs Added to Ongoing FDA Recall

Two More Blood Pressure Drugs Added to Ongoing FDA Recall

| Pharmaceutical Litigation
The U.S. Food and Drug Administration’s voluntary blood pressure drug recall continues as Torrent Pharmaceuticals Limited announced it is expanding its nationwide recall to include two blood pressure medications that were found to contain trace amounts of a potential cancer-causing carcinogen. The two medications are 3 lots of Losartan Potassium Tablets USP and 2 lots…Read the article
Fast Food, Teens and Depression

Fast Food, Teens and Depression

| Napoli Shkolnik News
You Are What You Eat High sodium and low potassium diets may contribute to teenage depression, according to a new study. This finding may impact both patients and providers. Such a diet indicates many processed foods and few fresh fruits and vegetables. Researchers at the University of Alabama-Birmingham found a conclusive link between depression and…Read the article
Uloric Lawsuit Claims and Process

Uloric Lawsuit Claims and Process

| Pharmaceutical Litigation
We trust our doctors and trained medical professionals to take care of us and recommended medications that will keep us safe and healthy and that won’t end up causing more harm than good. Unfortunately, more and more often these days, medications are being shown to have known risks and dangers associated with them. Many of…Read the article
What Is Taxotere Used For?

What Is Taxotere Used For?

| Pharmaceutical Litigation
If you caught our last article, What You Need to Know About Taxotere, the experienced pharmaceutical litigation team at Napoli Shkolnik PLLC explored what Taxotere is and why it is a dangerous pharmaceutical linked to permanent hair loss in breast cancer survivors treated with this drug. In short, Taxotere is an FDA-approved chemotherapy drug that…Read the article
The Types Of Breast Cancer

The Types Of Breast Cancer

| Pharmaceutical Litigation
More than 265,000 new cases of breast cancer are diagnosed. Despite sharing one name, there are several different types of breast cancers that develop in different parts of the breast and affect specific cells. Despite the numbers of new diagnoses and the myriad of different types, new treatments are becoming ever more effective, resulting in…Read the article
The Side Effects Of Chemotherapy For Breast Cancer

The Side Effects Of Chemotherapy For Breast Cancer

| Pharmaceutical Litigation
Chemotherapy has proven to be an effective way to combat the signs, symptoms, and effects of a wide variety of cancers, including breast cancer. When used, chemotherapy can increase the chance of a cure, reduce the likelihood that cancer will return, and can help breast cancer patients live a longer life. However, this treatment is…Read the article
What You Need To Know About Taxotere

What You Need To Know About Taxotere

| Pharmaceutical Litigation
In 2018, there were approximately 266,120 new cases reported of invasive types of breast cancer, along with another 63,960 cases reported of non-invasive types of breast cancer. For every eight women in the United States, at least one will develop some form of breast cancer over the course of her lifetime. These numbers are simply…Read the article
What You Should Know About Fournier’s Gangrene

What You Should Know About Fournier’s Gangrene

| Pharmaceutical Litigation
The U.S. Food and Drug Administration (FDA) issued a warning in late August 2018 about the link between diabetic medications and a rare, yet life-threatening disease called Fournier’s gangrene. The warning is specific to certain FDA-approved inhibitors (SGLT2), which are said to prevent the kidneys from reabsorbing sugar into the blood, therefore helping lower blood…Read the article